Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

36,949

Total recall recordsAll FDA and USDA recalls in Public Health Trace

9,732

Class I recallsReasonable probability of serious health consequences

24,263

Class II recallsTemporary or medically reversible health consequences

2,873

Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls

Most common hazardLack of assurance of sterility 2,071 recalls

Newest recallhttp://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/foods-alive-recalls-organic-moringa-leaf-powder-because-possible-health-riskPublished September 4, 2026

Most affected stateHawaii 200 recalls mention this state

State: PR ×
Clear all

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters

Timeline Classification Table

Metric

Time range

Group by

View

Recalls announced by month (Year to date)

Download CSV

Source: FDA and USDA public dataLast updated September 6, 2026 ET

Summary (Year to date)

1,458 recalls have been announced year to date.
Aug 2026 was 53% lower than the previous complete period (Jul 2026: 240).
The highest complete period was Jun 2026 (297).
Sep 2026 is incomplete and not included in the figures above.

Complete data
Incomplete

Recalls by class

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

Download CSV

Recalls by class
Class	Recalls
Class II	24,263
Class I	9,732
Class III	2,873
Not Yet Classified	1

FDA Recall Ongoing 2026 recordClass II

Dexamethasone Sodium Phosphate Injection, USP, 100 mg/ 10 mL, (10 mg/mL), 10x10 mL Multiple Dose Vials, Rx only, Manufactured for: Somerset Therapeutics, LLC., Somerset, NJ 08873, NDC carton: 70069-025-10; NDC vial: 70069-025-01

by SOMERSET THERAPEUTICS LLC

Reason: Failed Impurities/Degradation Specifications - OOS impurities result observed during long term stability testing at product expiry (24 months) were above specs for these impurities: Dexamethasone Sodium Phosphate EP impurity G (Impurity RU 49336) and dexamethasone formate.
Published: March 25, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

by STRIDES PHARMA INC

Reason: Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.
Published: March 25, 2026
Distribution: Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass III

Winder Laboratories, LLC

Product: Multivitamin with Fluoride Chewable Tablets Grape Flavor Rx…
Reason: Subpotent. During an FDA inspection it was discovered that the product was subpotent for Vitamin D.
Published: March 25, 2026
Distribution: Product was shipped to the following sta…

View recall →

FDA Recall Ongoing 2026 recordClass II

Icosapent Ethyl Capsules, 1 gram, 120 Capsules per bottle, Rx only, Manufactured by: Softgel Healthcare Pvt. Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534. NDC: 70710-1592-7

by Zydus Pharmaceuticals (USA) Inc

Reason: Failed Tablet/Capsule specifications: Red dots inside capsule and melted capsule caused by oxidized Icosapent ethyl, the active ingredient.
Published: March 18, 2026
Distribution: Nationwide

View recall →

FDA Recall United States Ongoing 2026 recordClass I

Ambrosia Brands LLC

Product: Rosabella brand MORINGA; DIETARY SUPPLEMENT CAPSULES; 60 cap…
Reason: Product may be contaminated with Salmonella
Published: March 18, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Amnesteem (Isotretinoin) Capsules, USP 40 mg, packaged in 3 x 10-Count Prescription Packs, Rx Only, Manufactured for: Mylan Pharmaceuticals Inc., Morgantown, WV, 26505 USA, Made in France, NDC 0378-6614-93.

by MYLAN PHARMACEUTICALS INC

Reason: Failed Dissolution Specifications
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

Mojo Max Fusion XXX, 500 mg, one capsule per blister card, 20 count box, Distributed by: Max Nutrition Inc. UPC 6 78945 36675 0

by Mohamed Hagar

Reason: Marketed Without an Approved NDA/ANDA-FDA analysis revealed undeclared sildenafil (13.1 mg/capsule) and tadalafil (13.8 mg/capsule).
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Sodium Iodide (I-131) Solution, Therapeutic Oral, packaged as a) 1 ml V-vial, NDC 69208-003-15; Order 49317, 49323, 49325, 49329, 49333, 49339, 49341,49355, 49364, 49380, 49392. (b) 2 ml V-Vial, NDC 69208-003-25; Order 49353,49457, 49477. (c) 3 ml V-vial, NDC 69208-003-35; Order 49454,49406. Rx Only, Manufactured by: International Isotopes Inc., Idaho Falls, ID.

by Radnostix

Reason: Presence of Particulate Matter: Due to production issues
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass I

SILINTAN 25/pills, packaged in a 25-count bottle, Shanghai Chinese Medical Works, Shanghai, China

by ANTHONY TRINH, 123Herbals LLC

Reason: Marketed Without an Approved NDA/ANDA: FDA analysis revealed the presence of undeclared meloxicam.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

MAXIMUM, ZONE 2, 4% Lidocaine Cream, (Lidocaine 4% and Epinephrine 0.01%), 1 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-015.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

MAXIMUM, ZONE 1, 4% Lidocaine Cream, 1/2 oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-014.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

FIVE-STAR, VASOCAINE Spray, (Lidocaine HCl 4%, Racepinephrine HCl 0.01%), 4oz bottles, Distributed By: Dermal Source, Portland, OR 97232, NDC 80069-016.

by HTO Nevada Inc. dba Kirkman

Reason: Stability Data Does Not Support Expiry Date.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Product label: Temozolomide Capsules, 5mg, packaged in 5-capsule bottles, Rx only, Manufactured for: Rising Pharmaceuticals, Inc., Allendale, NJ 07401, Country of origin: Taiwan, NDC 16571-816-51.

by Rising Pharma Holding, Inc.

Reason: Failed Impurities/Degradation Specifications: An out-of-specification result observed during 9th-month long term stability testing
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, Packaged and Distributed by: Major Pharmaceuticals, Indianapolis, IN 46268 USA, NDC 0904-6818-06.

by The Harvard Drug Group LLC

Reason: Defective container; inadequately sealed blister packaging.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Nilotinib Capsules, 200 mg per capsule, packaged in cartons, Rx only, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each), NDC 69097-032-74; Inner carton: 28 capsules (4 blisters of 7 capsules), NDC 69097-032-56; Foil blister: NDC 69097-032-17

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass III

Nilotinib Capsules, 150 mg per capsule, packaged in cartons, Rx only, Manufactured by: Cipla Ltd., Verna, Goa, India, Manufactured for: Cipla USA, Inc., 10 Independence Boulevard, Suite 300, Warren, NJ 07059, Outer carton: 112 capsules (4 individual packs containing 28 capsules each) NDC 69097-031-74; Inner carton: 28 capsules (4 blisters of 7 capsules) NDC 69097-031-56; Foil blister: NDC 69097-031-17

by Cipla USA, Inc.

Reason: Failed Tablet/Capsule Specifications: Observed OOS results at 6-months long-term stability condition for Description test and Appearance by Visual Inspection test.
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04; e) 100g, NDC 84385-106-05Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China.

by Harbin Jixianglong Biotech Co., Ltd.

Reason: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Semaglutide, For Rx compounding use only, packaged in a) 1g, NDC 84385-106-01; b) 5g, NDC 84385-106-02; c) 10g, NDC 84385-106-06; d) 25g, NDC 84385-106-03; d) 50g, NDC 84385-106-04 Manufacturer: Harbin Jixianglong Biotech Co., Ltd., North of Baoan Road, East of Changqing Street, Limin Development Zone, Harbin, China

by Harbin Jixianglong Biotech Co., Ltd.

Reason: CGMP Deviations This recall has been initiated due to failing to complete process validation and bacterial endotoxin method validation before distribution
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Antimicrobial Alcohol Hand Wipe, Isopropyl Alcohol 70%, Manufactured for : Custom Packaging Co., Inc, Louisville, KY 4023, NDC 0924-251-00.

by ACME UNITED CORPORATION

Reason: CGMP Deviations
Published: March 11, 2026
Distribution: Nationwide

View recall →

FDA Recall Ongoing 2026 recordClass II

Children's Healthcare of Atlanta, Instant Hand Sanitizing Wipe(Benzalkonium Chloride 0.13%), 1000 per case, Made in USA for Food Service Resources, Flowery Branch, GA 30542, NDC 0924-7130-00

by ACME UNITED CORPORATION

Reason: CGMP Deviations
Published: March 11, 2026
Distribution: Nationwide

View recall →

Data last updated: September 6, 2026 ET

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.